Realview Imaging

RealView Imaging is an Israeli startup founded in 2008 that has developed groundbreaking holographic technology for medical imaging applications. The company's flagship product, the HOLOSCOPE-i system, creates interactive, high-resolution 3D holograms from medical imaging data that float in free space. These holograms allow medical professionals to view and manipulate detailed anatomical structures during procedures without the need for special glasses or screens. The HOLOSCOPE-i renders hyper-realistic 3D holograms of a patient's anatomy that physicians can rotate, crop, mark, and measure using natural hand gestures. This technology aims to provide more intuitive visualization of complex anatomy compared to traditional 2D displays of 3D imaging data. RealView Imaging received FDA 510(k) clearance for the HOLOSCOPE-i in August 2021, paving the way for commercialization. The company's holographic system is designed for use in clinical settings like diagnostic clinics, hybrid operating rooms, and interventional suites. RealView Imaging's technology has the potential to transform fields like interventional cardiology by enabling physicians to interact with dynamic 3D holograms of organs during minimally invasive procedures.

Key customers and partnerships

In October 2013, RealView Imaging completed a clinical study of its holographic system in collaboration with Philips healthcare at Schneider Children's Medical Center in Israel. The study involved eight pediatric patients undergoing minimally invasive heart procedures. In 2023, Toronto General Hospital became the first healthcare facility globally to use RealView's holographic imaging for interventional cardiology procedures. RealView Imaging has also partnered with Philips healthcare to integrate its holographic technology with Philips' interventional X-ray systems.